NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." or the "Company") (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team: ht ...

Core Viewpoint - A class action securities lawsuit has been filed against Blue Owl Capital Inc. for alleged securities fraud affecting investors between February 6, 2025, and November 16, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Blue Owl Capital Inc. faced significant pressure on its asset base due to redemptions from business development companies, leading to undisclosed liquidity issues [2]. - It is alleged that the company may limit or halt redemptions of certain business development companies, which contradicts the positive statements made by the defendants regarding the company's business and prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until February 2, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States, with over 20 years of experience [4].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2] - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2] - The complaint indicates that there were significant manufacturing deficiencies in the facility related to the infant formula business [2] - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated [2] - The positive statements made by the defendants regarding Perrigo's business and prospects were materially misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the relevant time frame have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - Skye Bioscience, Inc. is facing a class action securities lawsuit due to alleged securities fraud that affected investors between November 4, 2024, and October 3, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that the company's lead product candidate, nimacimab, was less effective than previously represented, leading to overstated clinical, regulatory, and commercial prospects [2] - Defendants are accused of making materially false and misleading public statements regarding the effectiveness and prospects of nimacimab [2] Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Legal Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Integer Holdings Corporation ("Integer Holdings Corporation" or the "Company") (NYSE: ITGR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Integer Holdings Corporation investors who were adversely affected by alleged securities fraud between July 25, 2024 and October 22, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Klarna Group plc ("Klarna Group plc" or the "Company") (NYSE: KLAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Klarna Group plc investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons who purchased or otherwise acquired Klarna securities pursuant and/or traceable to the registration statement and related prospect ...

Core Viewpoint - A class action securities lawsuit has been filed against StubHub Holdings, Inc. due to alleged securities fraud affecting investors who purchased shares during the company's September 2025 initial public offering [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged securities fraud related to StubHub Holdings, Inc. [2] - The complaint alleges that the defendants made false statements and concealed significant changes in payment timing to vendors, which adversely impacted the company's free cash flow [3]. - It is claimed that the misleading reports on free cash flow and positive statements about the company's business operations lacked a reasonable basis [3]. Group 2: Investor Information - Investors who suffered losses in StubHub Holdings, Inc. during the relevant time frame have until January 23, 2026, to request appointment as lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securing compensation for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Primo Water Corporation and Primo Brands Corporation during specified periods about a class action lawsuit and the upcoming lead plaintiff deadline on January 12, 2026 [1]. Group 1: Class Action Details - Investors who purchased Primo Brands securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - To serve as lead plaintiff, individuals must file a motion with the court by January 12, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Background - The lawsuit pertains to the merger between Primo Water and BlueTriton Brands, which formed Primo Brands, a branded beverage company [5]. - Throughout the class period, the defendants allegedly misrepresented key facts about the merger, leading investors to believe in accelerated growth and operational efficiencies [5]. - The lawsuit claims that when the true details of the merger integration were revealed, investors suffered damages due to the misleading statements made by the defendants [5].

Core Viewpoint - A securities fraud lawsuit has been filed against Klarna Group plc and certain executives, alleging misleading statements in their IPO registration [1][2]. Group 1: Lawsuit Details - Klarna Group conducted its IPO at $40 per share on September 10, 2025 [2]. - The complaint claims that the Registration Statement contained false and misleading statements regarding the risk of loss reserves increasing shortly after the IPO [2]. - It is alleged that the defendants either knew or should have known about the risk profile of individuals taking Klarna's buy now, pay later loans, leading to materially false public statements [2]. Group 2: Investor Eligibility - Any investor who purchased Klarna Group plc common stock and experienced a decline in share value may be eligible to participate in the lawsuit, regardless of whether they sold their shares [3]. Group 3: Next Steps for Investors - The deadline to seek appointment as lead plaintiff is March 6, 2026, and a class has not yet been certified [4]. - Investors who have lost money are encouraged to contact Block & Leviton for further information [4]. Group 4: Whistleblower Information - Individuals with non-public information about Klarna Group are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [5]. Group 5: About Block & Leviton - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [6].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Nutanix, Inc. and its officers or directors, following disappointing financial results and a significant stock price drop [1][3][4]. Financial Performance - On November 25, 2025, Nutanix reported first-quarter fiscal year 2026 revenue that was near the lower end of its prior guidance, attributing this to a late quarter revenue shift due to increased customer demand for flexible start dates and growth through third-party OEM partners [3]. - The company revised its full-year revenue projection down from a range of $2.9 billion to $2.94 billion to a new range of $2.82 billion to $2.86 billion [3]. Stock Market Reaction - Following the announcement of the financial results, Nutanix's stock price fell by $10.43 per share, representing a 17.8% decline, closing at $48.34 per share on November 26, 2025 [4].